Deals for Juno and Bioverativ put CAR-T and hemophilia in spotlight

Celgene to get CAR T-cell immunotherapy maker Juno; Sanofi to acquire hemophilia-focused Bioverativ

Source: Chemical and Engineering News - January 22, 2018 Category: Chemistry Authors: Ryan Cross Source Type: research